Ticker
SGMOCompany Name
SANGAMO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Income Common Stock | Net Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -64.59M | -79.06% | $ 81.71M |
3/31/2025 | $ -80.74M | -126.63% | $ 63.76M |
12/31/2024 | $ -97.94M | -169.45% | $ 57.8M |
9/30/2024 | $ -136.13M | -260.33% | $ 52.29M |
6/30/2024 | $ -249.68M | -2033.68% | $ 12.28M |
3/31/2024 | $ -328.05M | -1749.06% | $ 18.76M |
12/31/2023 | $ -257.83M | -146.3% | $ 176.23M |
9/30/2023 | $ -249.51M | -123.87% | $ 201.42M |
6/30/2023 | $ -198.5M | -90.85% | $ 218.48M |
3/31/2023 | $ -127.17M | -52.76% | $ 241.03M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Revenues
(=) Net %
Net % for SANGAMO THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -75.84M ] / Revenues [ $ 147.24M ]
(=) Net % [ -51.5% ]
Minimum
Jun 30, 2024
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.2K |
---|---|
min | -64.23% |
max | 69.74% |
average | 4.77% |
median | 5.24% |
std | 19.84% |